18.31 USD
-0.42 (-2.24%)
18.31 USD
0 (0%)
Taking everything into account, KIDS scores 3 out of 10 in our fundamental rating. KIDS was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of KIDS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, KIDS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
KIDS had negative earnings in the past year.
KIDS had a negative operating cash flow in the past year.
In the past 5 years KIDS reported 4 times negative net income.
In the past 5 years KIDS always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of KIDS (-9.24%) is better than 62.70% of its industry peers.
KIDS has a Return On Equity of -13.06%. This is in the better half of the industry: KIDS outperforms 64.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.24% | ||
| ROE | -13.06% | ||
| ROIC | N/A |
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of KIDS (71.73%) is better than 81.08% of its industry peers.
In the last couple of years the Gross Margin of KIDS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for KIDS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
2. Health
2.1 Basic Checks
KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
KIDS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for KIDS has been increased compared to 5 years ago.
Compared to 1 year ago, KIDS has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.97 indicates that KIDS is not a great score, but indicates only limited risk for bankruptcy at the moment.
KIDS has a Altman-Z score of 1.97. This is comparable to the rest of the industry: KIDS outperforms 58.38% of its industry peers.
KIDS has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.28, KIDS is in line with its industry, outperforming 51.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.97 |
ROIC/WACCN/A
WACC9.8%
2.3 Liquidity
A Current Ratio of 7.40 indicates that KIDS has no problem at all paying its short term obligations.
KIDS has a Current ratio of 7.40. This is amongst the best in the industry. KIDS outperforms 87.57% of its industry peers.
KIDS has a Quick Ratio of 3.52. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of KIDS (3.52) is better than 70.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.4 | ||
| Quick Ratio | 3.52 |
3. Growth
3.1 Past
The earnings per share for KIDS have decreased strongly by -58.54% in the last year.
KIDS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.90%.
The Revenue has been growing by 23.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.06%
Revenue 1Y (TTM)19.9%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%12.23%
3.2 Future
The Earnings Per Share is expected to grow by 7.90% on average over the next years.
KIDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.05% yearly.
EPS Next Y1.04%
EPS Next 2Y10.64%
EPS Next 3Y12.33%
EPS Next 5Y7.9%
Revenue Next Year15.23%
Revenue Next 2Y13.82%
Revenue Next 3Y13.24%
Revenue Next 5Y13.05%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
KIDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year KIDS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
KIDS's earnings are expected to grow with 12.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.64%
EPS Next 3Y12.33%
5. Dividend
5.1 Amount
KIDS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
18.31
-0.42 (-2.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners70.96%
Inst Owner Change0%
Ins Owners5.08%
Ins Owner Change0.1%
Market Cap459.21M
Revenue(TTM)227.41M
Net Income(TTM)-45.61M
Analysts83.08
Price Target24.61 (34.41%)
Short Float %6.38%
Short Ratio5.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.35%
Min EPS beat(2)-89.58%
Max EPS beat(2)2.89%
EPS beat(4)1
Avg EPS beat(4)-50.67%
Min EPS beat(4)-115.9%
Max EPS beat(4)2.89%
EPS beat(8)3
Avg EPS beat(8)-27.23%
EPS beat(12)6
Avg EPS beat(12)-15.09%
EPS beat(16)9
Avg EPS beat(16)3.25%
Revenue beat(2)0
Avg Revenue beat(2)-3.13%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-2.47%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.82%
Revenue beat(16)4
Avg Revenue beat(16)-1.04%
PT rev (1m)-0.07%
PT rev (3m)-28.74%
EPS NQ rev (1m)-5.16%
EPS NQ rev (3m)-12.74%
EPS NY rev (1m)-1.37%
EPS NY rev (3m)-19.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.02 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.31 | ||
| P/tB | 2.76 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.95
EYN/A
EPS(NY)-1.26
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS9.07
BVpS13.93
TBVpS6.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.24% | ||
| ROE | -13.06% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.73% | ||
| FCFM | N/A |
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 74.39% | ||
| Cap/Sales | 6.41% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.4 | ||
| Quick Ratio | 3.52 | ||
| Altman-Z | 1.97 |
F-Score3
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.06%
EPS Next Y1.04%
EPS Next 2Y10.64%
EPS Next 3Y12.33%
EPS Next 5Y7.9%
Revenue 1Y (TTM)19.9%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%12.23%
Revenue Next Year15.23%
Revenue Next 2Y13.82%
Revenue Next 3Y13.24%
Revenue Next 5Y13.05%
EBIT growth 1Y-10.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.72%
EBIT Next 3Y49.9%
EBIT Next 5Y35.85%
FCF growth 1Y86.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.73%
OCF growth 3YN/A
OCF growth 5YN/A
ORTHOPEDIATRICS CORP / KIDS FAQ
What is the fundamental rating for KIDS stock?
ChartMill assigns a fundamental rating of 3 / 10 to KIDS.
Can you provide the valuation status for ORTHOPEDIATRICS CORP?
ChartMill assigns a valuation rating of 0 / 10 to ORTHOPEDIATRICS CORP (KIDS). This can be considered as Overvalued.
What is the profitability of KIDS stock?
ORTHOPEDIATRICS CORP (KIDS) has a profitability rating of 2 / 10.
How financially healthy is ORTHOPEDIATRICS CORP?
The financial health rating of ORTHOPEDIATRICS CORP (KIDS) is 4 / 10.
Is the dividend of ORTHOPEDIATRICS CORP sustainable?
The dividend rating of ORTHOPEDIATRICS CORP (KIDS) is 0 / 10 and the dividend payout ratio is 0%.